iBio, Inc.
IBIO
$4.86
-$0.22-4.33%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
2/19/2025
-
Globe Newswire
2/10/2025
-
Globe Newswire
1/13/2025
-
Globe Newswire
1/7/2025
-
Globe Newswire
1/2/2025
-
Globe Newswire
11/25/2024
-
Globe Newswire
11/12/2024
-
Globe Newswire
10/10/2024
-
Globe Newswire
9/20/2024
-
Globe Newswire
9/3/2024
-
Globe Newswire
8/12/2024
-
Globe Newswire
6/3/2024
-
Globe Newswire
5/13/2024
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, February 10, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
979 446 0027
Address
11750 Sorrento Valley Road
San Diego, CA 92121
San Diego, CA 92121
Country
Year Founded
Business Description
Sector
iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cancer, and other diseases. The company’s technology...
more
